Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden - Concepedia

Concepedia

Publication | Open Access

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

DOI Full Paper Access

149

Citations

20

References

2018

Year

Carl Morrison, Sarabjot Pabla, Jeffrey M. Conroy, Mary Nesline, Sean T. Glenn, Devin Dressman, Antonios Papanicolau‐Sengos, Blake Burgher, Jonathan Andreas, Vincent Giamo,

Journal for ImmunoTherapy of Cancer

Abstract

In this study, the response score derived from comprehensive immune profiling in a limited melanoma cohort showed improved predictive performance as compared to PD-L1 IHC and tumor mutational burden.

References

	Year	Citations

Page 1